Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.

Source:http://linkedlifedata.com/resource/pubmed/id/15703502

Download in:

View as

General Info

PMID
15703502